✦ LIBER ✦

Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a Phase II trial

✍ Scribed by Emilio Bajetta; Simonetta Chiara Stani; Daniela De Candis; Paolo Bidoli; Luigi Mariani; Nicoletta Zilembo; Paola Pozzi; Giuseppe Procopio

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 80 KB
Volume: 89
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20000815)89:4<763::aid-cncr7>3.0.co;2-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and vinorelbine in advanced

Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma : A Phase II study

✍ Rogerio Lilenbaum; Roberto Cano; Michael Schwartz; Leonard Siegel; Jose Lutzky; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

The authors conducted a Phase II study to evaluate the activity of the combination of gemcitabine and vinorelbine in patients with advanced nonsmall cell lung carcinoma (NSCLC). ## METHODS. Patients were eligible if they had Stage IIIB (malignant pleural effusion) or Stage IV NSCLC, no prior chemo

Flexible chemotherapy regimen with gemci

Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma : A Phase II multicenter trial

✍ Vera Hirsh; Adrian Langleben; Joseph Ayoub; Yvon Cormier; Javier Pintos; José L. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

Phase I trial of docetaxel and vinorelbi

Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma

✍ Vincent A. Miller; Kenneth K. Ng; Lee M. Krug; Wendy Perez; Barbara Pizzo; Rober 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Background: With preclinical evidence of synergy, this dose-finding trial examining the combination of docetaxel and vinorelbine given with prophylactic filgrastim for the treatment of patients with nonsmall cell lung carcinoma was undertaken. ## Methods: Twenty-seven patients with advanced no

Gemcitabine and vinorelbine in the secon

Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients : A Minnie Pearl Cancer Research Network Phase II trial

✍ John D. Hainsworth; Howard A. Burris III; Sharlene Litchy; Joan B. Erland; Jerem 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## BACKGROUND. Second-line chemotherapy for patients with nonsmall cell lung carcinoma has been ineffective due to the lack of activity of older agents following platinum-based therapy. This Phase II trial evaluated the feasibility, toxicity, and efficacy of two active new agents, gemcitabine and v

UFT plus cisplatin combination chemother

UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma : A multiinstitutional Phase II trial

✍ Yukito Ichinose; Kozo Yosimori; Shuichi Yoneda; Mutsuo Kuba; Shoji Kudoh; Hisano 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Background: Combination chemotherapy comprised of oral uft (a combination of tegafur and uracil) and cisplatin was shown to be an effective regimen for the treatment of advanced nonsmall cell lung carcinoma and to be associated with a low incidence rate of toxicity in a previous, single institut

A phase II study of gemcitabine plus ora

A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ Tony S. K. Mok; Benny Zee; Anthony T. C. Chan; Winnie Yeo; Wei Tse Yang; Anthony 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views